User profiles for P. Richmond

Peter Richmond

- Verified email at uwa.edu.au - Cited by 14039

Phillip A Richmond

- Verified email at bcchr.ca - Cited by 2870

Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape

…, H Nair, MC Nunes, O Ramilo, P Richmond… - The Lancet Infectious …, 2023 - thelancet.com
Respiratory syncytial virus is the second most common cause of infant mortality and a major
cause of morbidity and mortality in older adults (aged >60 years). Efforts to develop a …

Innate immunity in human newborn infants: prematurity means more than immaturity

T Strunk, A Currie, P Richmond, K Simmer… - The journal of …, 2011 - Taylor & Francis
Neonates, particularly those born prematurely, are exquisitely vulnerable to life-threatening
infections. This increased susceptibility to infection is maintained into childhood. Despite the …

[HTML][HTML] Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants

…, M Duron Padilla, PC Richmond… - … England Journal of …, 2023 - Mass Medical Soc
Background Whether vaccination during pregnancy could reduce the burden of respiratory
syncytial virus (RSV)–associated lower respiratory tract illness in newborns and infants is …

JASPAR 2020: update of the open-access database of transcription factor binding profiles

…, R Van der Lee, X Zhang, PA Richmond… - Nucleic acids …, 2020 - academic.oup.com
JASPAR ( http://jaspar.genereg.net ) is an open-access database of curated, non-redundant
transcription factor (TF)-binding profiles stored as position frequency matrices (PFMs) for …

Prevalence of respiratory viruses in community-acquired pneumonia in children: a systematic review and meta-analysis

MTG Pratt, T Abdalla, PC Richmond… - The Lancet Child & …, 2022 - thelancet.com
Background Respiratory viruses are increasingly detected in children with community-acquired
pneumonia but prevalence estimates vary substantially. We aimed to systematically …

[HTML][HTML] Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind …

P Richmond, L Hatchuel, M Dong, B Ma, B Hu… - The lancet, 2021 - thelancet.com
Background As part of the accelerated development of vaccines against severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), we report a dose-finding and adjuvant …

Effects of probiotics on atopic dermatitis: a randomised controlled trial

S Weston, A Halbert, P Richmond… - Archives of disease in …, 2005 - adc.bmj.com
Background: The aim of the study was to investigate the effects of probiotics on moderate or
severe atopic dermatitis (AD) in young children. Methods: Fifty six children aged 6–18 …

Polyploidy can drive rapid adaptation in yeast

AM Selmecki, YE Maruvka, PA Richmond, M Guillet… - Nature, 2015 - nature.com
… Under the above simplifying approximations of (1) a fixed population size and (2) a delta
distribution of fitness effects, the probability that a mutation will emerge and escape drift (P

[HTML][HTML] Respiratory syncytial virus vaccination during pregnancy and effects in infants

…, KP Perrett, JS Plested, PC Richmond… - … England Journal of …, 2020 - Mass Medical Soc
Background Respiratory syncytial virus (RSV) is the dominant cause of severe lower respiratory
tract infection in infants, with the most severe cases concentrated among younger infants…

Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal‐Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene …

…, CM Aalfs, C McMahon, P Richmond… - British journal of …, 1999 - Wiley Online Library
Hoyeraal‐Hreidarsson (HH) syndrome is a multisystem disorder affecting boys characterized
by aplastic anaemia (AA), immunodeficiency, microcephaly, cerebellar‐hypoplasia and …